Starbucks
SBUX
$99.07
+0.33%
Starbucks Corp is the world's largest and most recognizable coffee brand, operating nearly 41,000 cafes across more than 80 countries through a mix of company-operated stores (roughly 52%) and licensed locations, with revenue split across North America (74% of fiscal 2025 revenue), International (21%), and Channel Development (5%) segments. Its competitive identity rests on a vertically integrated, brand-driven platform: ultracustomizable beverages, a massive loyalty ecosystem, and a global real-estate footprint that competitors cannot easily replicate. The current investor narrative centers on a high-stakes turnaround under CEO Brian Niccol, focused on simplifying the menu, restoring speed of service, and cutting costs — including a reported initiative to build proprietary 'sovereign AI' aimed at removing roughly $400 million in annual software spending, alongside 300 corporate layoffs announced in May 2026. Debate among investors hinges on whether early signs of sales and profit recovery can be sustained against a choppy consumer backdrop and intensifying competition from fast-growing upstarts like Dutch Bros, which has been capturing significant investor attention in the coffee space.…
SBUX
Starbucks
$99.07
Related headlines
Investment Opinion: Should I buy SBUX Today?
The synthesized recommendation is Hold, with a constructive bias. The core thesis is that Starbucks is a credible but unproven turnaround where revenue growth of 8.79% and net margin recovery to 5.36% are real, but gross margin at 20.08% and a forward PE of 31.63x mean the market has already priced in substantial improvement. The analyst consensus of 'buy' with a mean of 2.33 and an average target of $112.23 (13.7% upside) supports holding rather than selling, but the wide target range of $81–$143 signals genuine disagreement about execution.
Supporting evidence for the Hold: revenue grew 8.79% year-over-year to $9.53 billion in Q2 2026; net income rose to $510.9 million from $384.2 million; trailing-twelve-month free cash flow is a healthy $2.73 billion; and the dividend yield of 2.84% provides income while waiting. However, the PS ratio of 2.63x and EV/Sales of 3.44x sit above typical fast-casual peers, and the forward PE of 31.63x compares to sector averages in the high-teens to mid-20s, meaning the premium is justified only if margins normalize. The operating margin of 9.63% remains well below the 14–18% range of 2023–2024, so the earnings recovery embedded in the $4.88 forward EPS estimate is not yet proven.
The biggest risks that could invalidate the thesis are a stall in gross margin recovery, a dividend cut if the payout ratio of 1.49 persists, and competitive share loss to Dutch Bros. This Hold would upgrade to Buy if gross margin climbs above 23% and forward PE compresses below 28x on stable estimates, or downgrade to Sell if revenue growth decelerates below 5% or the dividend is cut. Relative to its own history, the stock is expensive on trailing earnings but mid-range on forward numbers; relative to peers, it is clearly premium-priced, making it fairly valued at best and vulnerable to any execution miss.
Sign up to view all
SBUX 12-Month Price Forecast
Starbucks presents a balanced risk/reward at $98.74: the turnaround is showing real traction in revenue and net margin, but the stock's premium forward PE of 31.63x and depressed gross margin of 20.08% mean the easy money has already been made. The analyst consensus of 'buy' with a $112.23 average target offers modest upside, while the $81.00 low target and 52-week low of $77.99 define a credible 18–21% downside. The recent 8.99% monthly decline and -15.81 six-month relative strength versus SPY suggest the market is demanding proof before re-rating the stock higher. I would upgrade to bullish if gross margin exceeds 23% for two consecutive quarters and forward EPS estimates hold above $4.88, and downgrade to bearish if revenue growth falls below 5% or the dividend is cut. With a beta of 0.965 and a 2.84% dividend yield, the stock is best suited to patient investors willing to tolerate volatility while the margin story plays out.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Starbucks's 12-month outlook, with a consensus price target around $112.23 and implied upside of +13.3% versus the current price.
Average Target
$112.23
0 analysts
Implied Upside
+13.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$81 - $143
Analyst target range
Coverage is robust with 31 analysts following Starbucks, and the consensus recommendation is 'buy' with a recommendation mean of 2.33 (where 1 is strong buy and 5 is strong sell), indicating a moderately bullish tilt. The average price target is $112.23, which implies roughly 13.7% upside from the current price of $98.74, while the estimated average EPS of $4.88 for the forward year underpins the earnings recovery narrative. The consensus leans constructive but not euphoric — the 2.33 mean suggests more 'buy' than 'strong buy' ratings, reflecting lingering uncertainty about the pace of the turnaround and the margin recovery timeline. The target range is wide, spanning from a low of $81.00 to a high of $143.00 — a 76.5% spread that signals significant disagreement among analysts about the company's trajectory. The high target of $143 assumes successful execution of the turnaround, margin expansion back toward historical norms, and possibly multiple expansion as earnings normalize, while the low target of $81 prices in continued margin compression, competitive share loss to players like Dutch Bros, and a consumer slowdown. Recent institutional actions show a mix of upgrades and holds: TD Cowen upgraded to Buy from Hold in May 2026, Stifel maintained Buy, Baird and Evercore ISI stayed Outperform, while Citigroup, UBS, and DA Davidson remained Neutral and BNP Paribas maintained Underperform — a split that mirrors the wide target range and suggests the stock is a 'show-me' story where execution over the next two to three quarters will determine whether it converges toward the high or low end of the range.
Drowning in data?
Find the real signal!
Bulls vs Bears: SBUX Investment Factors
The bull case rests on tangible evidence: revenue growth of 8.79% year-over-year, net margin expansion from 4.39% to 5.36%, a 'buy' consensus with 13.7% upside to the $112.23 average target, and a credible $400 million cost-cutting initiative. The bear case is equally concrete: gross margin has collapsed to 20.08% from 26.25% in Q4 2024, the forward PE of 31.63x prices in a heroic earnings recovery, the payout ratio of 1.49 exceeds earnings, and the stock has lagged the S&P 500 by 15.81% over six months. On balance, the bear evidence currently has the stronger grip on near-term price action — the market is voting with its feet via the recent 8.99% monthly decline — but the bull case has more upside optionality if margin repair accelerates. The single most important tension is whether gross margin can climb back toward the mid-20s; if it does, the forward PE of 31.63x will look reasonable and the stock can converge toward $112–$143, but if it stalls near 20%, the premium multiple is vulnerable to a sharp de-rating.
Bullish
- Revenue reaccelerating under Niccol: Q2 2026 revenue of $9.53 billion grew 8.79% year-over-year, a sharp improvement from the prior-year quarter and evidence that the turnaround is producing top-line traction. The beverage category alone generated $5.66 billion, confirming the core product engine remains dominant.
- Net margin recovery underway: Q2 2026 net income of $510.9 million and a 5.36% net margin compare favorably to $384.2 million and 4.39% a year earlier, showing the profit recovery is real. Operating income of $777.3 million also rose from $601.0 million in the year-ago quarter.
- Analyst consensus sees 13.7% upside: With 31 analysts covering the stock, the consensus recommendation is 'buy' (mean 2.33) and the average target price of $112.23 implies roughly 13.7% upside from $98.74. The high target of $143.00 suggests meaningful optionality if execution accelerates.
- Sovereign AI could cut $400M in costs: Starbucks is building proprietary AI to replace Microsoft and IBM software, targeting roughly $400 million in annual software savings. Combined with 300 corporate layoffs announced in May 2026, these cost actions could materially lift margins if delivered.
Bearish
- Gross margin collapse vs. history: Gross margin of 20.08% in Q2 2026 is far below the 26.25% reported in Q4 2024 and the 27.9% seen in Q3 2024, reflecting heavy investment in labor, supply chain, and menu simplification. The operating margin of 9.63% is also well short of the 14–18% range delivered in 2023–2024.
- Valuation leaves no room for error: The trailing PE of 52.54x and forward PE of 31.63x sit at a premium to fast-casual peers in the high-teens to mid-20s. The forward multiple embeds an aggressive assumption that earnings roughly double from a depressed base, so any stumble would likely trigger multiple compression.
- Negative equity and weak liquidity: Debt-to-equity of -3.29 reflects negative book equity from buybacks, while the current ratio of just 0.72 means current liabilities exceed current assets. The company relies on operating cash flow to service obligations, leaving little buffer if margins stall.
- Dividend payout exceeds earnings: A payout ratio of 1.49 means the $706.3 million paid in Q2 2026 dividends exceeded net income of $510.9 million. With quarterly FCF volatile — just $91.8 million in Q2 2026 versus $1.27 billion in Q1 2026 — dividend sustainability is a genuine question.
SBUX Technical Analysis
Starbucks is in a broad recovery trend that has stalled in recent months, with the stock up 19.89% over the past year but trading at $98.74, which is only about 63.7% of its 52-week range (low of $77.99, high of $110.51). That positioning — well off the highs but far above the lows — suggests the post-2025 rebound has lost momentum rather than reversed, leaving the stock in a wide consolidation zone. The 1-year gain of 19.89% also modestly outperformed the S&P 500's 16.22% over the same period, though that relative strength has been eroding sharply of late. Recent momentum is clearly negative: the stock is down 8.99% over the past month and 4.17% over three months, a stark deceleration from the positive 1-year trend. Relative strength versus SPY is -7.93 over one month and -7.21 over three months, meaning Starbucks has lagged the market badly during this pullback, and the 6-month relative strength of -15.81 confirms sustained underperformance since spring. With a beta of 0.965, the stock is slightly less volatile than the market, so this decline is stock-specific rather than a high-beta selloff, pointing to company or sector-specific concerns. Key technical levels are well defined: support sits near the 52-week low of $77.99, with intermediate support around the $95–$96 area where the stock consolidated in June 2026, while resistance is the 52-week high of $110.51, last touched in mid-August. A breakout above $110.51 would signal the turnaround narrative is regaining traction and could open a move toward analyst targets in the $112–$143 range, whereas a breakdown below $95 would threaten a retest of the $86–$87 March 2026 lows and potentially the $77.99 floor. The maximum drawdown of -16.69% over the period underscores that this is a stock capable of meaningful corrections even with a sub-1.0 beta, so position sizing should account for event risk around earnings and turnaround execution.
Beta
0.96
0.96x market volatility
Max Drawdown
-16.7%
Largest decline past year
52-Week Range
$78-$111
Price range past year
Annual Return
+21.0%
Cumulative gain past year
| Period | SBUX Return | S&P 500 |
|---|---|---|
| 1m | -8.0% | -2.0% |
| 3m | -2.6% | +1.4% |
| 6m | +6.9% | +15.0% |
| 1y | +21.0% | +15.7% |
| ytd | +18.0% | +11.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SBUX Fundamental Analysis
Starbucks' revenue trajectory is reaccelerating modestly, with the most recent quarter (ending March 29, 2026) delivering $9.53 billion in revenue, up 8.79% year-over-year versus $8.76 billion in the year-ago quarter. Sequentially, revenue has been choppy — $9.91 billion in Q1 2026, $9.53 billion in Q2 2026, and $9.57 billion in Q4 2025 — reflecting a business that is growing but not yet firing on all cylinders, with the beverage category ($5.66 billion) dominating the mix over food ($1.83 billion) and other products ($2.04 billion). The YoY growth of 8.79% is a meaningful improvement from the prior-year quarter's performance and supports the thesis that Niccol's turnaround is producing top-line traction, though the sequential dip from Q1 to Q2 warrants monitoring for signs of demand fatigue. Profitability is improving but remains well below historical norms: Q2 2026 net income was $510.9 million with a net margin of 5.36%, up from $384.2 million and a 4.39% net margin in the year-ago quarter, while gross margin came in at 20.08% — a sharp compression from the 26.25% gross margin reported in Q4 2024. The gross margin decline reflects investments in labor, supply chain, and menu simplification, and while the net margin recovery is encouraging, the gap between current gross margins (~20%) and the 26–29% range seen in 2023–2024 highlights how much margin repair remains ahead. The balance sheet carries meaningful leverage and negative equity, with a debt-to-equity ratio of -3.29 and a current ratio of just 0.72, indicating that current liabilities exceed current assets and the company relies on operating cash flow to service obligations. Free cash flow on a trailing-twelve-month basis is $2.73 billion, but quarterly FCF has been volatile — just $91.8 million in Q2 2026 versus $1.27 billion in Q1 2026 — and the company paid $706.3 million in dividends during Q2 alone, a payout ratio of 1.49 that exceeds earnings and raises questions about dividend sustainability at current profit levels. ROE is negative at -22.93% (distorted by negative book equity from buybacks), while ROA of 8.02% shows the underlying asset base still generates reasonable returns; the key risk is that heavy capital expenditure ($272.7 million in Q2 2026) plus dividend commitments could strain liquidity if the margin recovery stalls.
Quarterly Revenue
$9.5B
2026-03
Revenue YoY Growth
+8.8%
YoY Comparison
Gross Margin
20.1%
Latest Quarter
Free Cash Flow
$2.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SBUX Overvalued?
Because Starbucks is profitable — Q2 2026 net income of $510.9 million and trailing EPS of $0.019 — the PE ratio is the appropriate primary metric, and it tells a complex story: the trailing PE stands at 52.54x while the forward PE is 31.63x, a gap that implies the market expects earnings to roughly double over the next year. That expectation is aggressive but consistent with the turnaround thesis, as forward EPS estimates of $4.88 versus trailing EPS near zero reflect a normalization of profitability from a depressed base rather than organic earnings power. The forward PE of 31.63x is the more meaningful figure for valuation, and it embeds substantial recovery assumptions. Relative to the broader restaurant sector, Starbucks trades at a significant premium: its PS ratio of 2.63x and EV/Sales of 3.44x sit above typical fast-casual peers, while the forward PE of 31.63x compares to sector averages that generally range in the high-teens to mid-20s. The premium is partially justified by Starbucks' brand strength, global scale, and 2.84% dividend yield, but it also reflects turnaround optimism that has yet to be fully validated by margin recovery — gross margin of 20.08% remains far below the 26%+ levels of 2024, and the operating margin of 9.63% is well short of the 14–18% range the company delivered in 2023–2024. Against its own history, Starbucks looks expensive on trailing metrics but less so on forward numbers: the trailing PE of 52.54x is near the high end of its 5-year range (which has spanned roughly 18x to 178x during earnings troughs), while the PS ratio of 2.63x is actually near the low end of its historical band of roughly 9.6x to 17.6x — a discrepancy explained by the collapse in trailing earnings. The forward PE of 31.63x sits in the middle of the historical range, suggesting the market is pricing in a successful but not heroic recovery; if margins normalize toward 2024 levels, the stock could re-rate higher, but if the recovery stalls, the premium multiple leaves little room for error.
PE
52.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 18x~48x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
22.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are elevated by the combination of negative book equity (debt-to-equity of -3.29), a current ratio of just 0.72, and a dividend payout ratio of 1.49 that exceeds Q2 2026 net income of $510.9 million. Quarterly free cash flow is highly volatile — $91.8 million in Q2 2026 versus $1.27 billion in Q1 2026 — while capital expenditure of $272.7 million and $706.3 million in quarterly dividends consume most of the cash generated. Gross margin at 20.08% remains roughly 600 basis points below the 26.25% level of Q4 2024, meaning the company is still absorbing heavy labor and supply-chain investments without a clear timeline for recapture. If the margin recovery stalls, the company could face a liquidity squeeze that forces either a dividend cut or reduced store investment, both of which would damage the turnaround narrative.
Market and competitive risks center on valuation compression and share loss. The forward PE of 31.63x and EV/EBITDA of 22.50x sit at a premium to fast-casual peers, leaving the stock vulnerable to multiple contraction if growth disappoints; the trailing PE of 52.54x is near the high end of its 5-year range. Dutch Bros has been capturing significant investor attention and expanding aggressively, with recent news highlighting its 52-week high and long-term growth prospects, directly threatening Starbucks' younger-customer base. With a beta of 0.965, the stock is slightly less volatile than the market, so the recent 8.99% monthly decline and -15.81 six-month relative strength versus SPY are stock-specific rather than macro-driven. A choppy consumer backdrop and any further deterioration in discretionary spending would pressure same-store sales, particularly in the North America segment that generates 74% of revenue.
The worst-case scenario would be a simultaneous margin stall and demand slowdown: gross margin stays near 20%, revenue growth decelerates below 5%, and the market re-rates the stock toward the analyst low target of $81.00, which is roughly 18% below the current $98.74. A more severe outcome would retest the 52-week low of $77.99, implying a decline of approximately 21% from current levels, and the maximum drawdown of -16.69% over the past period shows this stock can correct sharply even with a sub-1.0 beta. If the dividend were cut to preserve cash, income-oriented investors could exit and accelerate the decline toward the $77.99 floor. In this adverse scenario, an investor could lose 18–21% from the current price, with the $81.00 analyst low serving as the first downside checkpoint.
FAQ
The most severe risk is margin stagnation: gross margin of 20.08% is roughly 600 basis points below Q4 2024 levels, and failure to improve would undermine the forward PE of 31.63x. Second is dividend sustainability, with a payout ratio of 1.49 exceeding Q2 2026 net income of $510.9 million and quarterly FCF of just $91.8 million. Third is competitive pressure from Dutch Bros, which has been capturing investor attention and expanding aggressively, threatening Starbucks' younger-customer base. Fourth is balance-sheet risk, with a current ratio of 0.72 and negative book equity (debt-to-equity of -3.29) leaving little buffer if operating cash flow weakens.
The 12-month forecast is split: a 50% probability base case targets $105–$118, aligned with the analyst average of $112.23, assuming gradual margin improvement and forward EPS of $4.88 being met. A 25% probability bull case targets $125–$143, driven by gross margin recovery above 23% and successful delivery of the $400 million AI cost savings. A 25% probability bear case targets $78–$85, reflecting margin stagnation, a dividend cut, and competitive share loss. The base case is most likely, with the key assumption being that revenue growth holds near 8% and gross margin improves modestly toward 22%.
SBUX appears fairly valued to slightly overvalued on forward metrics. The forward PE of 31.63x sits above fast-casual peers in the high-teens to mid-20s, and the EV/EBITDA of 22.50x is also premium. However, the PS ratio of 2.63x is near the low end of its historical band of roughly 9.6x to 17.6x, a discrepancy explained by the collapse in trailing earnings. The market is pricing in a successful but not heroic recovery, with forward EPS of $4.88 roughly double the trailing figure. If gross margin normalizes toward 24–26%, the stock could re-rate higher; if it stalls near 20%, the premium multiple is at risk.
From a risk/reward perspective, SBUX is a reasonable but not compelling buy at $98.74. The analyst consensus target of $112.23 implies 13.7% upside, while the analyst low target of $81.00 and 52-week low of $77.99 imply 18–21% downside, creating a roughly balanced skew. The bull case rests on 8.79% revenue growth and net margin recovery to 5.36%, but the bear case points to a 20.08% gross margin and a forward PE of 31.63x that leaves little room for error. It is a good buy for patient investors with a 12–18 month horizon who believe the margin recovery will materialize, but less attractive for those seeking immediate upside or income safety given the 1.49 payout ratio.
SBUX is better suited for long-term investment than short-term trading. With a beta of 0.965, the stock is slightly less volatile than the market, but the maximum drawdown of -16.69% and recent 8.99% monthly decline show it can correct sharply around earnings and turnaround news. The 2.84% dividend yield and the multi-year nature of the margin recovery argue for a holding period of at least 12–18 months to allow the turnaround to play out. Short-term traders face event risk around quarterly earnings and the wide analyst target range of $81–$143, which makes timing difficult. A minimum holding period of 12 months is suggested for investors seeking to capture the potential re-rating.
